|
|
| Home | Featured Companies | Virtual Trading Game | Stock Market Blogs | Financial Tools | Sign Up & Play For Free | |
| SGX Pharmaceuticals, Inc. | |
||||||||||||||||||||||||||||||||||||||||||||||||||||
| SGX Pharmaceuticals, Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SGXP | Last: $2.94 ($-0.01) | Volume: 264,538 | Last Trade: 7/25/2008 5:20:07 PM | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Today
Today | Last 7 Days | 1 Month | 3 Month | 6 Month | 1 Year |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| SGX Pharmaceuticals, Inc. Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| SGX Pharmaceuticals is a biotechnology company that focuses on the discovery, development and commercialization of cancer therapeutics. Co.'s principal drug discovery are on protein and enzyme targets that have been implicated in cancers, including BCR-ABL, MET, JAK2 and RAS. Co. is also building an internal oncology product pipeline and generating lead compounds, which are drug-like small molecules with characteristics that have the potential to be appropriate for treatment of disease, through the application of its approach to drug discovery that is based upon the use of small fragments of drug-like molecules, known as Fragments of Active Structures. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| SGX Pharmaceuticals, Inc. News & Press Releases | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393 SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals SGXP today announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for SGX393. This compound is an internally... [more] SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update SAN DIEGO, May 13 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals SGXP today announced its financial results for the first quarter of 2008. For the three months ending March 31, 2008, the Company posted total revenues of $17.0 million and n... [more] SGX Pharmaceuticals to Present at the BioCentury Future Leaders in ... Genetic Engineering News (press release): SGX Pharmaceuticals, Inc. ( Nasdaq: SGXP ) will be presenting at the Future Leaders in the Biotech Industry ... SGX Pharmaceuticals Announces Fourth Quarter and Full Year ... Lifescience-online: SGX Pharmaceuticals Announces Fourth Quarter and Full Year ... , Switzerland - Mar 13, 2008 SGX Pharmaceuticals ( Nasdaq: SGXP - News) today announced financial results for the year and fourth quarter ended December 31, 2007. For the SGX Pharmaceuticals Schedules Teleconference and Webcast for ... FOXBusiness: SGX Pharmaceuticals ( Nasdaq: SGXP ) will announce financial results for the fourth quarter and ... SGX Pharmaceuticals Announces Fourth Quarter and Full Year 2006 ... Drug Newswire (press release): SGX Pharmaceuticals ( NASDAQ:SGXP ) today announced financial results for the fourth quarter and year ended ... SGX Pharmaceuticals to Host Research & Development Luncheon Genetic Engineering News (press release): SGX Pharmaceuticals, Inc. ( Nasdaq: SGXP ) will be hosting a Research & Development Luncheon on Thursday, February 15, ... SGX Pharmaceuticals to Present at the BIO CEO & Investor Conference PR Newswire (press release): SGX Pharmaceuticals, Inc. ( Nasdaq: SGXP ) will be presenting at the BIO CEO & Investor Conference on February 14, 2007 at 1:30 pm ... SGX Pharmaceuticals to Host Research & Development Luncheon Genetic Engineering News (press release): SGX Pharmaceuticals, Inc. ( Nasdaq: SGXP ) will be hosting a Research & Development Luncheon on Thursday, February 15, ... SGX Pharmaceuticals to Present at the BIO CEO & Investor Conference Genetic Engineering News (press release): SGX Pharmaceuticals, Inc. ( Nasdaq: SGXP ) will be presenting at the BIO CEO & Investor Conference on February 14, 2007 at 1:30 pm ... SGX moves forward with cancer treatment San Diego Daily Transcript (subscription): , CA - Feb 7, 2007 SGX Pharmaceuticals Inc. ( Nasdaq: SGXP ) announced Wednesday that the company has selected a tumor treatment for preclinical development. ... SGX Pharmaceuticals Selects Development Candidate for MET Tyrosine ... PipelineReview.com (press release): SGX Pharmaceuticals Selects Development Candidate for MET Tyrosine ... , Spain - Feb 2, 2007 SAN DIEGO, CA, USA | Feb 01, 2006 | SGX Pharmaceuticals, Inc. ( Nasdaq: SGXP ) today announced that the company has selected a MET tyrosine ki SGX Pharmaceuticals Presenting on MET Development Candidate at ... PR Newswire (press release): SGX Pharmaceuticals, Inc. ( Nasdaq: SGXP ) today announced that it will present data on its MET tyrosine kinase inhibitor ... |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | Companies | Game | Blogs | Savings Calculator | Tools | Contact Us | Disclosure | Site Map | Sign Up | Copyright © 2008 SmallCapWatch, LLC. |
| Never invest based soley on information from this website or our e-mail and IM alerts | |
